Introduction {#Sec1}
============

More than 1.7 million people die from cancer in Europe each year, and the WHO predicts that the number will increase to over 2.1 million by 2020 (a 24% increase) \[[@CR1]\]. Estimates show that each year, 1.6 million cancer patients in Europe experience pain related to their disease, and one third of them will require complex treatment \[[@CR2]\]. The number experiencing other distressing symptoms is also high \[[@CR2]\]. Therefore palliative and end-of-life (EOL) care must be an essential component of cancer care and equally scientifically and evidence based. However, research in palliative care/EOL care constitutes a very minor part of European cancer research. In the UK, less than 0.2% of research spending in cancer addresses palliative and EOL care \[[@CR2]\]. Similar figures are not known for most other European countries, but are likely to be even lower for many of them.

Research in EOL care did not appear systematically on the agenda in Europe until the 1990 s with the establishment of the European Association for Palliative Care (EAPC) and its Research Network (EAPC-RN) in 1996 \[[@CR3]\]. However, there is still little coordination of research in EOL cancer care in Europe today \[[@CR4]\]. This may be due to lack of agreement on what constitutes EOL care, scarce information on public or clinical priorities, few appropriate measures of quality, and a lack of established best practice \[[@CR5]\]. Methodological, organisational, attitudinal, and societal challenges have been identified, as well as a lack of research knowledge/skills in the area of EOL care research \[[@CR6]--[@CR9]\]. For the purposes of PRISMA, EOL care is defined as care in the last year of life.

In recent years, some well-funded palliative care research initiatives have emerged in Europe, Canada, the USA and Australia \[[@CR10]--[@CR13]\]. PRISMA is a project within the European Commission's Seventh Framework Programme with the overall purpose to deliver an integrated programme to co-ordinate research priorities, public priorities, and practice in EOL cancer care in Europe, with a focus on measurement \[[@CR14]\]. In order to develop a future research agenda and strategic plan for EOL care in Europe, an overview of current research resources, activities, and challenges must be established. To our knowledge, no such overview currently exists. The National Cancer Research Institute's Strategic Planning Group on Supportive and Palliative Care report (SuPaC) \[[@CR15]\] examined the past and present state of UK research in the field of supportive and palliative care for cancer, identified needs and opportunities for the future, clarified specific issues and barriers, and developed proposals for national strategic actions. An analysis of research workforce capacity and stakeholder views was in the form of a questionnaire survey. In addition to this survey from the UK, EOL care research has been surveyed in Latin America \[[@CR16]\] and Australia \[[@CR17]\]. The survey from Latin America (17 countries) aimed to determine the current status of palliative care research in Latin America. In order to develop a palliative research network in Queensland, Australia, a survey was conducted to map the current research activity, create a database and identify problems that had been encountered in undertaking research \[[@CR17]\].

The aim of the present study was to conduct a questionnaire survey to map EOL cancer care research across Europe and to identify priorities, needs and barriers in this research area.

Material and methods {#Sec2}
====================

Questionnaire {#Sec3}
-------------

A cross-sectional online self-completed survey comprising 62 items was developed in English ([Electronic Supplementary Material](#MOESM1){ref-type=""}). The survey focused on clinical research in adults with cancer in their last year of life. Clinical research was defined as research directly involving patients or family members/care givers. The questions addressed research conducted in the previous 3 years, current ongoing research, and future plans. In addition to demographic characteristics, questions were related to research topics, methodology and trial design, staffing, organisation and funding, quality indicators (completed doctoral degrees in the last 3 years, number of publications in peer-reviewed journals last 3 years, number of conference abstracts last 3 years), and priorities in, and barriers to, research.

An outline of the contents of the questionnaire was developed at the first meeting of PRISMA work package 3 (WP3). Based on this draft and consulting identified related surveys \[[@CR15]--[@CR17]\], two WP3 members selected and designed questions. The draft was circulated to all WP3 members and PRISMA work package leads for comments. Some of the items were adapted from the SuPaC survey \[[@CR15]\]. The list of EOL care research topics was based on the abstract categories used for the EAPC conferences and the list of research topics used in the SuPaC survey \[[@CR3], [@CR15]\].

A web-based solution was developed using SelectSurveyASP Advanced 8.1.10 software \[[@CR18]\]. It was pilot tested by nine experts in EOL care. Respondent access level was single response. Respondents returning a completed survey could edit their original responses. The survey was designed with a combination of mandatory and optional responses. Skip logic was used.

Sample {#Sec4}
------

We wanted to include all chairs in palliative medicine, palliative care or EOL care in Europe. In countries without such chairs, palliative care researchers or other identified contact persons were approached. Through the EAPC, Open Society Institute, UK Hospice Information Service, leaders of national associations for palliative care and/or palliative medicine in European countries, literature searches, and a number of international contacts, a list of 233 contacts in a total of 41 European countries was identified. At the country level, e-mails were sent with information about the survey and lists of proposed respondents in each country, asking about chairs in palliative medicine and also if important researchers were missing from our list. Contacts in 28 countries responded to our inquieries. By January 2009, a list of 201 chairs, researchers or other contact persons in 41 European countries had been compiled. All of these received a personal invitation to participate by e-mail with a link to the survey. In addition, an open invitation to participate was posted on the websites of the EAPC \[[@CR3]\] and the European Palliative Care Research Collaborative \[[@CR11]\].

The data collection started on the 30th of April 2009 and closed after 1 month. Reminders were sent to non-responders after 2 and 3 weeks.

Analyses {#Sec5}
--------

The data was cleaned and checked to identify and correct potential divergence/errors and ensure missing data was coded uniformly. The responses were entered into an SPSS database version 15.0. Data was analyzed using descriptive statistics.

We hypothesised that the state of EOL care research in a country would be linked to the development of palliative care in that country. Due to the limited number of responses from many countries it would be difficult to compare countries or even regions within Europe. We decided to divide the countries into two groups based on their level of palliative care development, as described by the International Observatory on End-of-Life Care in 2008 \[[@CR19]\]. The following categorisation was developed through a multi-method approach combining published and grey literature, information from websites, directories, and databases, expert opinion, and the work of a task force of the European Association for Palliative Care \[[@CR19]\]: Countries with developed palliative care (i.e. countries where palliative care activities are approaching integration with mainstream service providers): Austria, Belgium, Denmark, Finland, France, Germany, Hungary, Iceland, Ireland, Italy, Netherlands, Norway, Poland, Romania, Slovenia, Spain, Sweden, Switzerland, and UK.Countries with underdeveloped palliative care (i.e., countries with localised palliative care provision only): Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Greece, Latvia, Lithuania, Luxembourg, Moldova, Montenegro (no known activity), Portugal, Russia, Serbia, and Ukraine.

Ethics {#Sec6}
------

We contacted the Regional Committee for Medical Research Ethics in Central Norway. Due to the nature of the study no application was required.

Results {#Sec7}
=======

Responses {#Sec8}
---------

We received 127 responses from the 201 invited contacts. The responses came from 36 European countries (Table [1](#Tab1){ref-type="table"}). A further eight replies were submitted in response to the open invitation on the websites. Eight responses were excluded, three duplicates and five non-serious responses submitted through the websites. Table 1Number of responses per countryCountryResponsesAustria7Belarus1Belgium4Bosnia and Herz2Bulgaria2Croatia1Czech Republic1Denmark5Estonia1Finland1France3Georgia3Germany6Greece4Hungary3Iceland1Ireland5Italy7Latvia2Lithuania1Luxembourg1Moldova1Montenegro1Netherlands7Norway6Poland7Portugal6Romania1Russia2Serbia1Slovenia2Spain8Sweden8Switzerland3Ukraine1UK12

Altogether, 127 responses were eligible for analysis: 104 complete (all mandatory questions answered) and 23 incomplete responses. Respondents were 69 (54.3%) male and 58 (45.7%) female, mean age of 49.4 (range, 28--74) years.

Location of research groups {#Sec9}
---------------------------

Seventy-one of the 127 groups were located in either a teaching hospital (44) or a cancer centre (27), with a further 18 being on a university campus but not attached to a hospital. Ten groups were based in hospices and eight in district general hospitals.

Work force {#Sec10}
----------

The survey showed that 85% of the scientific team leaders were physicians (104/123), most commonly with a palliative medicine background, followed by oncology.

The survey identified a total of 965 research staff in 88 groups. The mean number of members in a research group was 11 (1--58); 460 (48%) had part-time and 505 (52%) full-time positions. Eighty-three groups reported a total of 371 research staff having combined positions with clinical work.

Ninety-two groups reported on their research staff. Seventy-three (79%) of these groups had scientific team leaders who were professors or held another academic position (95 team leaders in all), 67 groups had a total of 128 experienced/senior researchers, and 52 groups reported having a total of 119 early researchers or post-docs. There were 172 Ph.D. students in 54 groups, and 32 groups had a total of 111 Master degree students. More than half of the current Ph.D. students are in the few large groups. Thirty groups reported having managers/administrators, and 33 groups reported a total head count of 59 technical staff.

Most of the groups were small: 45% of the groups had one to five members, and 28% six to ten members. Thirteen groups (14%) were defined as large groups, having more than 15 members.

Thirty-nine of the groups were multidisciplinary, defined as having four or more different disciplines represented among the research staff. A wide range of professions contribute to the research workforce, including physicians (35%), nurses (29%), psychologists (8%) and sociologists (4%) (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Discipline of the research staff in 88 groups. Numbers working full time and part time. Note that physicians are spread over several categories

Research network, collaboration and strategy {#Sec11}
--------------------------------------------

National collaboration with other palliative care research groups was reported by 77/92 groups (84%); 60/92 (65%) reported international research collaboration.

Four out of 33 countries (12%) reported to have a formalised palliative care research network (Estonia, France, Switzerland and Ukraine; Estonia and Ukraine had only one respondent each). Twelve countries answered this question with both "yes" and "no". Twenty-four of 33 countries (73%) reported no national strategy for EOL care research; from eight countries (24%) there were both "yes" and "no" answers to this question. One country reported having a national strategy for EOL care research; however, this country had only one respondent.

Funding {#Sec12}
-------

Seventy-four of the 92 groups (80%) answered the question concerning funding sources; 63 (85%) of these had specific funding for research on EOL care. Out of this number, 60 were groups in countries with developed palliative care services. The funding sources were governmental (76%), institutional (45%), pharmaceutical (45%), charity (42%), international (33%), scientific awards (30%), and private (16%).

Research completed in the last 3 years {#Sec13}
--------------------------------------

One hundred and four (86%) out of 121 research groups reported completed research on EOL care in the previous 3 years. Ninety-six groups (92%) reported on their specific areas of research and the most frequently reported areas were pain (82%), assessment and measurement tools (69%), last days of life and quality of death (56%), other symptoms (55%), and policy and the organisation of services (53%).

A total of 1,714 (median, 11; range, 0--149) conference abstracts were published from 89 research groups in the last 3 years.

The total number of publications in peer-reviewed journals in the last 3 years was 1,329 (median, 7; range 0--154) from the 89 groups. Nine groups had no publications. Five percent of the publications were from countries with underdeveloped palliative care services. Most of the groups (75%) had published papers in journals with an impact factor ≤5. Only 8% of the groups had published papers in journals with impact factor \>10 \[[@CR20]\]. Journal of Pain and Symptom Management, Palliative Medicine, and Supportive Care in Cancer were the three most common publication journals. The majority of publications were in palliative care journals, followed by general oncology journals to a lesser extent.

The large research groups had 48% of the reported publications in peer-reviewed journals, and 34% of the reported conference abstracts the previous 3 years. The average number of publications per person was two for the large groups and 1.6 for the small groups. The two largest groups had an average of 3.9 publications per person.

The total number of reported Ph.D. degrees or equivalent obtained during the previous 3 years was 119 (mean, 1.3; range, 0--8). Twelve (10%) of the 119 degrees were obtained in countries with underdeveloped palliative care services. Forty-one Ph.D. degrees (34%) were completed in the large groups. Forty-four (49%) out of 90 research groups answering this question reported one or more completed Ph.D. degrees in this time period.

Ongoing research {#Sec14}
----------------

Ninety-five research groups were carrying out EOL care research at the time of the survey. Eighty-four percent of the research was conducted in countries with developed palliative care services (16 countries). In 90/95 groups (95%) the research was directly involving patients, and in 54/95 (57%) directly involving family members.

Figure [2](#Fig2){ref-type="fig"} reports the research topics, reported by 94 groups. The most frequently reported areas of research were pain (70%), assessment and measurement tools (63%), other symptoms (52%), last days of life and quality of death (44%), and family and caregivers (40%). Fig. 2Ongoing research. Research topics. Number of groups

The research methodologies reported by the groups (*n* = 89) were clinical trials (74%), audit and quality control (51%), health service research (38%), production of guidelines (34%), systematic reviews and meta-analysis (31%), epidemiology (30%), basic research (15%) and translational research (12%).

The study designs of the clinical trials (*n* = 66) were randomised controlled trials (65%), observational studies (61%), prospective nonrandomized trials (58%), qualitative studies (47%), retrospective studies (35%), and cross-sectional studies (32%).

Barriers to EOL care research {#Sec15}
-----------------------------

Figure [3](#Fig3){ref-type="fig"} presents barriers in general (*n* = 104). More than half of the groups considered the following barriers of importance: lack of funding (85%), lack of time (64%), insufficient knowledge and expertise (62%), lack of personnel (54%), and lack of infrastructure and support (52%). Groups in countries with underdeveloped palliative care services reported more lack of technical support (52% vs 35%), lack of research training programmes (67% vs 42%), and lack of a national research agenda (63% vs 43%). On the other hand, countries with developed palliative care services reported more often clinical issues (51% vs 18%), lack of time (69% vs 52%), and staff gate keeping (21% vs 7%) as barriers. Fig. 3Barriers in general. Number of groups

Priorities for the field {#Sec16}
------------------------

Figure [4](#Fig4){ref-type="fig"} presents the future research priorities for the field (*n* = 104). More than half of the groups reported that research on last days of life and quality of death (63%), pain (61%), fatigue and cachexia (60%), assessment and measurement tools (59%), cognitive symptoms and delirium (56%), policy and the organisation of services (54%), and communication (51%) should be prioritised. Fig. 4Priorities for the field concerning future research on adults with cancer in their last year of life. Number of groups

Discussion {#Sec17}
==========

To our knowledge, this is the first study reporting on the current state of EOL cancer care research across Europe. The most frequently reported current research areas were pain, assessment and measurement tools, other symptoms, and last days of life and quality of death. The results show that although some large groups were identified, most of the research groups were small. Almost 50% of all positions were part time. Very few European countries reported to have a formalised palliative care research network. Lack of funding was the most commonly reported barrier.

Workforce {#Sec18}
---------

A previous, limited survey of palliative care research in 13 European countries suggested that there were very few groups reaching a critical size \[[@CR21]\]. This impression is confirmed by the present study. Even though a few large groups exist, the picture is dominated by small and scattered groups and initiatives, without national or international coordination. The few large groups reported almost half of the publications, and more than half of the current Ph.D. students are in these groups. These findings are also well in line with the SuPaC report \[[@CR15]\], which also found that the palliative care research workforce was fragmented across multiple sites; there were inadequate numbers of postdoctoral and senior lecturers, and scarce infrastructure, with poor access to expertise in research methodology.

Our findings show a great need for structured collaboration both nationally and internationally to promote EOL cancer care research in Europe. Larger groups should try to include smaller groups in their work. Studies have shown that research groups are complex interacting systems with a strong size dependency, and that is it important to achieve critical mass \[[@CR22]\].

Research topics and methodology {#Sec19}
-------------------------------

The most frequently reported areas of completed research were pain, assessment and measurement tools, last days of life and quality of death, other symptoms, and policy and the organisation of services. Ongoing research showed the same areas, but less research on policy and organisation, and more on family and caregivers. All these areas were included in the list of the most common research topics in the SuPaC report of 2004 \[[@CR15]\]; however, the most commonly reported area of research in the SuPaC survey was psychological research, followed by information/communication. While the SuPaC report was restricted to the UK, the present survey had respondents from 36 European countries.

The strong focus on symptomatology may reflect the predominantly medical sample in our survey. However, symptom relief is at the core of palliative care, and a review of palliative care research publications by Kaasa and co-workers in 2006 found that symptom control/management was one of the two most frequent topic areas, service development (policy and organisation) being the other \[[@CR21]\]. The literature review \[[@CR21]\] indicated that the majority of research publications in palliative care were surveys and descriptional/observational studies, and that rather few randomised, controlled trials were published. These findings were confirmed in 2008 in a paper on research methodologies in palliative care \[[@CR23]\]. In the present survey, 66 out of 89 groups reported conducting clinical trials, and the most common study design for the clinical trials was the randomised controlled trial (65% of the groups), followed by observational studies (61%) and prospective nonrandomized trials (58%). Randomised, controlled trials remain the gold standard for evidence, and a development with more groups doing this type of studies would be very welcome. However, it remains to be seen whether this finding will be reflected in publications over the next years.

Barriers {#Sec20}
--------

More than half of the groups reported lack of funding, lack of time, insufficient knowledge and expertise, lack of personnel and lack of infrastructure support as barriers to EOL care research. Similar barriers have been identified by others \[[@CR15]--[@CR17], [@CR24]\]. Almost one third of the responders in the present study had no specific funding for EOL care research. Sixty-three groups had specific funding for research on EOL care and 60 of these were groups in countries with developed palliative care services. Thus the state of palliative care research is closely linked to the development of clinical palliative care services in a country. Research collaboration between countries with developed palliative care services and countries with less developed palliative care could also enhance the development of clinical palliative care services in the latter. Ear-marked funding to boost the efforts can be crucial in these countries.

Our data shows that almost half of the research staff (48%) had combined clinical and research posts. People in combined positions often face serious difficulties in relation to pressure from clinical commitments, and this might result in lack of time being ranked as the second most important barrier. This point is important to address when planning combined clinical and academic careers.

Priorities {#Sec21}
----------

A number of research topics were identified as priority areas for the future (Fig. [4](#Fig4){ref-type="fig"}). The future priority areas identified by the respondents were very similar to the areas in which the respondents were currently working (Fig. [2](#Fig2){ref-type="fig"}), except that research into the last days of life and quality of death emerged as a stronger priority. It is possible that the respondents often prioritised areas of research with which they were already familiar. However, several of the priority topics from the present survey overlap with the ten areas identified with urgent need for increased research efforts at the Birmingham International Workshop on Supportive, Palliative, and End-of-life Care Research in 2005 \[[@CR25]\]. The Birmingham group also included symptomatology in their priority areas: measuring symptoms and symptoms clusters, study of the biological bases of complex symptom clusters and enhancing research in symptom interventions. The priority areas identified in the present survey have later been further developed in an international workshop with 30 participants from 25 European countries selected from the survey responders \[[@CR26]\]. These priorities, as defined by clinicians and researchers, will later be integrated with public priorities and preferences in the context of PRISMA and give guidance to coordinating bodies aiming to promote pan-European research \[[@CR14]\].

Study limitations {#Sec22}
-----------------

The present study is the first broad survey of EOL care research in Europe. The invitation to participate in the survey was sent to all chairs (professors) in EOL care, palliative care, and palliative medicine in Europe, and to other leaders of research groups in these areas that we were able to identify. Despite our broad approach to identify professionals involved in relevant research, we might have missed groups, especially research groups dealing with EOL care issues in areas defined outside EOL care or palliative care.

Although the survey had a high response rate (67%), there might be a selection bias among the respondents. The majority of responders belonged to countries with developed palliative care (76%). However, this is where most EOL care research groups are located. The majority of the scientific team leaders in the responding groups were physicians. This predominance has probably led to more biomedically oriented answers than if researchers from other professions had been asked about their priorities.

The language, format and contents of the survey questionnaire, especially the proffered lists of response options, represent additional limitations. One example is the list of EOL care research topics, which also was used for defining future needs and priorities.

Conclusions {#Sec23}
===========

The results of this pan-European survey demonstrate that EOL cancer care research is in its infancy. Small and scattered groups and initiatives without national or international coordination dominate the picture. However, a few large groups exist. These large groups reported almost half of the publications, and more than half of today's Ph.D. students are in these groups.

We conclude that there is a great need for structured collaboration both nationally and internationally to promote palliative and EOL cancer care research in Europe. The EAPC-RN, the European Palliative Care Research Centre \[[@CR27]\] and Cicely Saunders Institute \[[@CR28]\] all have important roles in facilitating future EOL care research and organising collaborative research efforts. Hopefully this will facilitate high-quality research within Europe and enhance the development of clinical palliative care.

Electronic supplementary material {#AppESM1}
---------------------------------

Below is the link to the electronic supplementary material.
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